1. "Nursing"
Formats
  1. Journal Article (1702)
  2. Meeting Abstract (1536)
  3. Book Section (121)
  4. Review (103)
  5. Editorial (78)
  6. Conference Paper (26)
  7. Research Letter (17)
  8. Book Whole (15)
  9. Miscellaneous (13)
  10. Correspondence (12)
  11. Guidelines (10)
Groups
  1. Nursing (3633)
  2. Department of Medicine (1470)
  3. Advanced Practice Providers (1108)
  4. Survivorship Research (942)
  5. Solid Tumor Oncology Division (863)
  6. Epidemiology and Biostatistics (622)

More Groups

People
  1. William Rosa (199)
  2. Nessa Coyle (123)
  3. Sergio Giralt (115)
  4. Mark Kris (113)
  5. Howard Scher (100)
  6. Andrew Zelenetz (97)

More People

Years
  1. 2025 (73)
  2. 2024 (204)
  3. 2023 (196)
  4. 2022 (204)
  5. 2021 (171)
  6. 2020 (179)

More Years

Publications
  1. Journal of Clinical Oncology (448)
  2. Oncology Nursing Forum (389)
  3. Blood (207)
  4. Clinical Journal of Oncology Nursing (119)
  5. Biology of Blood and Marrow Transplantation (88)
  6. Clinical Cancer Research (69)

More Publications

Publishers
  1. Oncology Nursing Society (ONS) (533)
  2. American Society of Clinical Oncology (487)
  3. Elsevier Inc. (455)
  4. Lippincott Williams & Wilkins (255)
  5. American Society of Hematology (220)
  6. American Association for Cancer Research (155)

More Publishers

Results (3633)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Docetaxel clearance and cisplatin administration: Implications for toxicity of docetaxel, cisplatin, and fluorouracil (DCF) in gastric cancer
    Meeting Abstract

    Power, D. G.; Wu, N.; Qin, W.; Sully, D.; Cisek, C.; Randazzo, J.; Ritch, P. S.; Jhawer, M. P.; Kelsen, D. P.; Shah, M. A.
    Journal of Clinical Oncology (2008)

    Fulltext@MSK | Save
  • Phase II trial of neoadjuvant temozolomide in advanced melanoma
    Meeting Abstract

    Shah, G. D.; Coit, D. G.; Brady, M.; Wolchok, J. D.; Carvajal, R. D.; Busam, K.; Panageas, K.; Roman, R.; Viale, A.; Socci, N.; more...
    Journal of Clinical Oncology (2008)

    Fulltext@MSK | Save
  • Does CTCAE toxicity symptom reporting by patients or clinicians predict clinical outcomes?
    Meeting Abstract

    Basch, E. M.; Jia, X.; Barz, A.; Heller, G.; Culkin, A.; Appawu, M.; Barnett, T.; Jason, F.; Kris, M. G.; Schrag, D.
    Journal of Clinical Oncology (2008)

    Fulltext@MSK | Save
  • Phase I trial of bevacizumab plus sunitinib in patients with metastatic renal cell carcinoma
    Meeting Abstract

    Feldman, D. R.; Ginsberg, M. S.; Baum, M.; Flombaum, C.; Hassoun, H.; Velasco, S.; Fischer, P.; Ishill, N. M.; Ronnen, E. A.; Motzer, R. J.
    Journal of Clinical Oncology (2008)

    Fulltext@MSK | Save
  • Survival rates after resection for localized kidney cancer: 1989-2004
    Meeting Abstract

    Jang, T. L.; Pettus, J. A.; Huang, W. C.; Eggener, S. E.; O'Brien, M. F.; Karellas, M. E.; Kagiwada, M. A.; Russo, P.
    Journal of Clinical Oncology (2008)

    Fulltext@MSK | Save
  • Hereditary diffuse gastric cancer (HDGC): Clinical characteristics of a prospective cohort
    Meeting Abstract

    Shah, M. A.; Sheehy, E.; Harlan, M.; Randazzo, J.; Perera, R. J.; Pascarelli, K.; Kemeny, M. M.; Schrag, D.; Coit, D. G.; Kelsen, D. P.
    Journal of Clinical Oncology (2008)

    Fulltext@MSK | Save
  • A phase I study of FOLFOX administered with flavopiridol (F) in patients with refractory solid tumors
    Meeting Abstract

    Dickson, M. A.; Carvajal, R. D.; Shah, M. A.; Cane, L. M.; Dials, H. J.; Schwartz, G. K.
    Journal of Clinical Oncology (2008)

    Fulltext@MSK | Save
  • Pilot trial of a Wilms tumor-1 (WT1) peptide vaccine in patients with thoracic and myeloid neoplasms
    Meeting Abstract

    Brown, A. B.; Krug, L. M.; Maslak, P.; James, L. P.; Dao, T.; Tyson, L.; Chanel, S. M.; Bekele, S.; Scheinberg, D. A.
    Journal of Clinical Oncology (2008)

    Fulltext@MSK | Save
  • Final results of a phase I study of picoplatin and pegylated liposomal doxorubicin in advanced solid tumor malignancies
    Meeting Abstract

    Dizon, D. S.; Maluf, F.; Aghajanian, C. A.; Daud, A. I.; Sabbatini, P.; Pezzulli, S.; Soigne, S.; Spriggs, D. R.
    Journal of Clinical Oncology (2008)

    Fulltext@MSK | Save
  • A novel capecitabine dosing schedule combined with bevacizumab is safe and active in patients with metastatic breast cancer: A phase II study
    Meeting Abstract

    Traina, T. A.; Theodoulou, M.; Dugan, U.; Feigin, K.; Patil, S.; Edwards, C.; Norton, L.; Hudis, C. A.
    Journal of Clinical Oncology (2008)

    Fulltext@MSK | Save